Literature DB >> 22037722

Efficacy of a topical suspension of bacterial antigens for the management of chronic suppurative otitis media.

Renzo Mora1, Francesco Antonio Salzano, Enzo Mora, Luca Guastini.   

Abstract

The aim of this study was to compare the efficacy and safety of a topical suspension of bacterial antigens for the management of chronic suppurative otitis media (CSOM). Two-hundred ten patients with CSOM were enrolled in this study. The patients were divided into two numerically equal groups and randomized to receive a topical suspension of bacterial antigens, Lantigen B (group A), or placebo (group B), according to the following protocol: 5 drops thrice a day for 12 consecutive weeks in the external acoustic duct. The topical suspension of bacterial antigens and placebo were administered by identical, anonymous dispensers in order to maintain double-blind conditions. Before, at the end and 3 months, and after the end of the treatment, all patients who entered in the study underwent pure tone audiometry, microscopic examination of ears, microbiological examination of the ear swab, aural suctioning and subjective assessment of symptoms by visual analog scale. In group A, we saw a statistically significant improvement in the different items measured. A topical suspension of bacterial antigens was significantly more effective than placebo in the treatment of CSOM.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22037722     DOI: 10.1007/s00405-011-1816-3

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  22 in total

1.  [APROPOS OF THE TREATMENT OF SEVERAL OTORHINOLARYNGOLOGICAL DISEASES WITH LANTIGEN B AEROSOLS].

Authors:  A DUPERRET
Journal:  J Med Bord       Date:  1964-07

Review 2.  Chronic suppurative otitis media: a review.

Authors:  Monique Verhoeff; Erwin L van der Veen; Maroeska M Rovers; Elisabeth A M Sanders; Anne G M Schilder
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2005-09-27       Impact factor: 1.675

3.  Immunoglobulin-coated bacteria in effusions from secretory and chronic suppurative otitis media.

Authors:  L E Stenfors; S Räisänen
Journal:  Am J Otolaryngol       Date:  1991 May-Jun       Impact factor: 1.808

4.  Efficacy of a topical suspension of bacterial antigens for the management of recurrent eczema in children.

Authors:  Renzo Mora; Luisa Bellussi; Francesco Maria Passali; Barbara Crippa; Francesco Mora; Maria Paola Cordone; Marco Barbieri
Journal:  Med Sci Monit       Date:  2004-08-20

5.  Serum and middle ear immunoglobulins in suppurative otitis media.

Authors:  Akeem O Lasisi; Olatubosun G Arinola; Rasheed A Bakare
Journal:  ORL J Otorhinolaryngol Relat Spec       Date:  2008-11-04       Impact factor: 1.538

6.  Diagnosis of spontaneous bacterial peritonitis: Role of tween 80 and triton X in ascitic fluid cultures.

Authors:  R N Iyer; D Kapoor
Journal:  Indian J Med Microbiol       Date:  2009 Apr-Jun       Impact factor: 0.985

7.  Impact of mastoidectomy on simple tympanic membrane perforation repair.

Authors:  Benjamin M McGrew; C Gary Jackson; Michael E Glasscock
Journal:  Laryngoscope       Date:  2004-03       Impact factor: 3.325

8.  The prevalence of chronic otitis media and its complication rates in teenagers and adult patients.

Authors:  Yung Song Lin; Li-Ching Lin; Fei-Peng Lee; Kuan Ji Lee
Journal:  Otolaryngol Head Neck Surg       Date:  2009-02       Impact factor: 3.497

9.  Intranasal vaccination with recombinant P6 protein and adamantylamide dipeptide as mucosal adjuvant confers efficient protection against otitis media and lung infection by nontypeable Haemophilus influenzae.

Authors:  Gustavo M Bertot; Pablo D Becker; Carlos A Guzmán; Saúl Grinstein
Journal:  J Infect Dis       Date:  2004-03-17       Impact factor: 5.226

10.  The effect of topical ciprofloxacin and steroid-containing ear drops for chronic suppurative otitis media on the internal ear.

Authors:  Zeliha Kapusuz; Erol Keles; Hayrettin Cengiz Alpay; Turgut Karlidag; Irfan Kaygusuz; Ali Kemal Uzunlar; Israfil Orhan; Sinasi Yalcin
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-01       Impact factor: 2.503

View more
  3 in total

1.  Broncho-Vaxom® (OM-85 BV) soluble components stimulate sinonasal innate immunity.

Authors:  Vasiliki Triantafillou; Alan D Workman; Neil N Patel; Ivy W Maina; Charles C L Tong; Edward C Kuan; David W Kennedy; James N Palmer; Nithin D Adappa; Salomon Waizel-Haiat; Noam A Cohen
Journal:  Int Forum Allergy Rhinol       Date:  2019-01-07       Impact factor: 3.858

2.  The bacterial lysate Lantigen B reduces the number of acute episodes in patients with recurrent infections of the respiratory tract: the results of a double blind, placebo controlled, multicenter clinical trial.

Authors:  Fulvio Braido; Giovanni Melioli; Piero Candoli; Andrea Cavalot; Mario Di Gioacchino; Vittorio Ferrero; Cristoforo Incorvaia; Carlo Mereu; Erminia Ridolo; Giovanni Rolla; Oliviero Rossi; Eleonora Savi; Libero Tubino; Giorgio Reggiardo; Ilaria Baiardini; Eddi di Marco; Gilberto Rinaldi; Giorgio Walter Canonica; Carlo Accorsi; Claudia Bossilino; Laura Bonzano; Michela DiLizia; Barbara Fedrighini; Valentina Garelli; Vincenzo Gerace; Sara Maniscalco; Ilaria Massaro; Alessandro Messi; Manlio Milanese; Silvia Peveri; Arminio Penno; Stefano Pizzimenti; Tiziana Pozzo; Alberto Raie; Sergio Regina; Francesca Sclifò
Journal:  Immunol Lett       Date:  2014-11-03       Impact factor: 3.685

3.  Topical antibiotics for chronic suppurative otitis media.

Authors:  Christopher G Brennan-Jones; Karen Head; Lee-Yee Chong; Martin J Burton; Anne Gm Schilder; Mahmood F Bhutta
Journal:  Cochrane Database Syst Rev       Date:  2020-01-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.